Literature DB >> 27821766

Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.

Angel Diaz-Lagares1, Ana B Crujeiras1,2,3, Paula Lopez-Serra1, Marta Soler1, Fernando Setien1, Ashish Goyal4,5, Juan Sandoval1, Yutaka Hashimoto1, Anna Martinez-Cardús1, Antonio Gomez1, Holger Heyn1, Catia Moutinho1, Jesús Espada6,7, August Vidal8, Maria Paúles8, Maica Galán9, Núria Sala10, Yoshimitsu Akiyama11, María Martínez-Iniesta12, Lourdes Farré12,13, Alberto Villanueva12, Matthias Gross4,5, Sven Diederichs4,5,14,15,16, Sonia Guil17, Manel Esteller17,18,19.   

Abstract

Long noncoding RNAs (lncRNAs) are important regulators of cellular homeostasis. However, their contribution to the cancer phenotype still needs to be established. Herein, we have identified a p53-induced lncRNA, TP53TG1, that undergoes cancer-specific promoter hypermethylation-associated silencing. In vitro and in vivo assays identify a tumor-suppressor activity for TP53TG1 and a role in the p53 response to DNA damage. Importantly, we show that TP53TG1 binds to the multifaceted DNA/RNA binding protein YBX1 to prevent its nuclear localization and thus the YBX1-mediated activation of oncogenes. TP53TG1 epigenetic inactivation in cancer cells releases the transcriptional repression of YBX1-targeted growth-promoting genes and creates a chemoresistant tumor. TP53TG1 hypermethylation in primary tumors is shown to be associated with poor outcome. The epigenetic loss of TP53TG1 therefore represents an altered event in an lncRNA that is linked to classical tumoral pathways, such as p53 signaling, but is also connected to regulatory networks of the cancer cell.

Entities:  

Keywords:  DNA methylation; cancer; epigenetics; long noncoding RNA

Mesh:

Substances:

Year:  2016        PMID: 27821766      PMCID: PMC5127373          DOI: 10.1073/pnas.1608585113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  The p53MH algorithm and its application in detecting p53-responsive genes.

Authors:  J Hoh; S Jin; T Parrado; J Edington; A J Levine; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

Review 2.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

Review 3.  lncRNAs and microRNAs with a role in cancer development.

Authors:  Julia Liz; Manel Esteller
Journal:  Biochim Biophys Acta       Date:  2015-07-04

Review 4.  Regulation of MDM2 Stability After DNA Damage.

Authors:  Jiaqi Li; Manabu Kurokawa
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

5.  Putative cis-regulatory drivers in colorectal cancer.

Authors:  Halit Ongen; Claus L Andersen; Jesper B Bramsen; Bodil Oster; Mads H Rasmussen; Pedro G Ferreira; Juan Sandoval; Enrique Vidal; Nicola Whiffin; Alexandra Planchon; Ismael Padioleau; Deborah Bielser; Luciana Romano; Ian Tomlinson; Richard S Houlston; Manel Esteller; Torben F Orntoft; Emmanouil T Dermitzakis
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

Review 6.  DNA methylation profiling in the clinic: applications and challenges.

Authors:  Holger Heyn; Manel Esteller
Journal:  Nat Rev Genet       Date:  2012-09-04       Impact factor: 53.242

7.  Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.

Authors:  Miguel Vizoso; Humberto J Ferreira; Paula Lopez-Serra; F Javier Carmona; Anna Martínez-Cardús; Maria Romina Girotti; Alberto Villanueva; Sonia Guil; Catia Moutinho; Julia Liz; Anna Portela; Holger Heyn; Sebastian Moran; August Vidal; Maria Martinez-Iniesta; Jose L Manzano; Maria Teresa Fernandez-Figueras; Elena Elez; Eva Muñoz-Couselo; Rafael Botella-Estrada; Alfonso Berrocal; Fredrik Pontén; Joost van den Oord; William M Gallagher; Dennie T Frederick; Keith T Flaherty; Ultan McDermott; Paul Lorigan; Richard Marais; Manel Esteller
Journal:  Nat Med       Date:  2015-06-01       Impact factor: 53.440

Review 8.  MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use.

Authors:  S Patrick Nana-Sinkam; Carlo M Croce
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis.

Authors:  F Nikulenkov; C Spinnler; H Li; C Tonelli; Y Shi; M Turunen; T Kivioja; I Ignatiev; A Kel; J Taipale; G Selivanova
Journal:  Cell Death Differ       Date:  2012-07-13       Impact factor: 15.828

Review 10.  Considerations when investigating lncRNA function in vivo.

Authors:  Andrew R Bassett; Asifa Akhtar; Denise P Barlow; Adrian P Bird; Neil Brockdorff; Denis Duboule; Anne Ephrussi; Anne C Ferguson-Smith; Thomas R Gingeras; Wilfried Haerty; Douglas R Higgs; Eric A Miska; Chris P Ponting
Journal:  Elife       Date:  2014-08-14       Impact factor: 8.140

View more
  60 in total

Review 1.  Role of epigenomic mechanisms in the onset and management of insulin resistance.

Authors:  Andrea G Izquierdo; Ana B Crujeiras
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 2.  Non-coding RNA networks in cancer.

Authors:  Eleni Anastasiadou; Leni S Jacob; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2017-11-24       Impact factor: 60.716

3.  LINC00261 Is an Epigenetically Regulated Tumor Suppressor Essential for Activation of the DNA Damage Response.

Authors:  Shandy Shahabi; Vishaly Kumaran; Jonathan Castillo; Zhengmin Cong; Gopika Nandagopal; Daniel J Mullen; Alexander Alvarado; Michele Ramos Correa; Autumn Saizan; Riya Goel; Amrita Bhat; Sean K Lynch; Beiyun Zhou; Zea Borok; Crystal N Marconett
Journal:  Cancer Res       Date:  2019-02-22       Impact factor: 12.701

Review 4.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

Review 5.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

Review 6.  Ketotherapy as an epigenetic modifier in cancer.

Authors:  Borja Bandera-Merchan; Hatim Boughanem; Ana B Crujeiras; Manuel Macias-Gonzalez; Francisco J Tinahones
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

7.  Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer.

Authors:  Juan He; Ke Wu; Chenglin Guo; Jian-Kang Zhou; Wenchen Pu; Yulan Deng; Yuanli Zuo; Yun Zhao; Lunxu Liu; Yu-Quan Wei; Yong Peng
Journal:  Cell Mol Life Sci       Date:  2018-10-06       Impact factor: 9.261

Review 8.  Long non-coding RNAs involved in different steps of cancer metastasis.

Authors:  P Suman; Y Chhichholiya; P Kaur; S Ghosh; A Munshi
Journal:  Clin Transl Oncol       Date:  2022-02-04       Impact factor: 3.405

9.  Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

Authors:  Sabina Sanegre; Núria Eritja; Carlos de Andrea; Juan Diaz-Martin; Ángel Diaz-Lagares; María Amalia Jácome; Carmen Salguero-Aranda; David García Ros; Ben Davidson; Rafel Lopez; Ignacio Melero; Samuel Navarro; Santiago Ramon Y Cajal; Enrique de Alava; Xavier Matias-Guiu; Rosa Noguera
Journal:  Front Cell Dev Biol       Date:  2021-06-03

10.  Long Non-Coding RNA TP53TG1 Upregulates SHCBP1 to Promote Retinoblastoma Progression by Sponging miR-33b.

Authors:  Hongyi Wang; Zhen Zhang; Yue Zhang; Shihai Liu; Li Li
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.